EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Chemistry and Bioactivity of Mefenamic Acid Derivatives: A Review of Recent Advances

Hifza Mustafa, Saima Daud, Sabahat Sheraz, Maria Bibi, Tauseef Ahmad, Asma Sardar, Tanzeela Fazal, Asma Khan, Obaid-Ur-Rahman Abid

Archiv der Pharmazie · 2025

DOI: 10.1002/ardp.70004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Hifza Mustafa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Abbottabad University of Science and Technology, Abbottabad, Pakistan. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Mefenamic Acid, Antineoplastic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: The authors received no specific funding for this study..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mefenamic acid (MA) represents an efficient nonsteroidal anti‐inflammatory drug (NSAID) for treatment in many circumstances of painful conditions and inflammation, but its poor water solubility and gastrointestinal side effects often obstruct its clinical application. Consequently, researchers have been conducting studies on the synthesis of prodrugs and heterocyclic compounds as MA derivatives for the improvement of their pharmacological profile. This review discusses an overview of recent developments in the synthesis and biological applications of MA derivatives. It covers several strategies used to modify the chemical structure of MA to pursue pharmacokinetic improvement, solubility, and targeting features, among which are heterocyclic moieties and prodrug design. Following the many synthetically produced derivatives of MA, mainly proposed between classic organic synthesis and more recent methodologies, such as microwave‐assisted synthesis and green chemistry protocols, this review will consider how different structural variations are able to influence the assumed pharmacological actions: analgesic, anti‐inflammatory, and anticancer. The findings demonstrate significant progress toward the development of safer and more effective NSAID therapies; thus, they support, in a broad and unprecedented way, the potential of MA derivatives and prodrugs in transforming the state of pain management and inflammation treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Inflammatory Agents, Non-SteroidalMefenamic AcidAntineoplastic AgentsHumansAnimalsProdrugsStructure-Activity RelationshipMolecular StructureSolubilityPainInflammation

Stichwörter der Autor:innen

NSAIDsanthranilic acid derivativesbiological activityheterocyclic compoundsmefenamic acid

Substanzen

Anti-Inflammatory Agents, Non-SteroidalMefenamic AcidProdrugsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Chemistry, Abbottabad University of Science and Technology, Abbottabad, Pakistan.
  • Department of Chemistry, Fatima Jinnah Woman University, Rawalpindi, Pakistan.
  • Department of Chemistry, Hazara University, Mansehra, Pakistan.

Förderung

  • The authors received no specific funding for this study.

Zitieren

APA

Mustafa, H., Daud, S., Sheraz, S., Bibi, M., Ahmad, T., Sardar, A., Fazal, T., Khan, A., & Abid, O. U. (2025). The Chemistry and Bioactivity of Mefenamic Acid Derivatives: A Review of Recent Advances. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70004

Vancouver

Mustafa H, Daud S, Sheraz S, Bibi M, Ahmad T, Sardar A, et al. The Chemistry and Bioactivity of Mefenamic Acid Derivatives: A Review of Recent Advances. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70004

BibTeX
@article{Mustafa2025,
  author = {Mustafa, Hifza and Daud, Saima and Sheraz, Sabahat and Bibi, Maria and Ahmad, Tauseef and Sardar, Asma and Fazal, Tanzeela and Khan, Asma and Abid, Obaid-Ur-Rahman},
  title = {The Chemistry and Bioactivity of Mefenamic Acid Derivatives: A Review of Recent Advances},
  journal = {Archiv der Pharmazie},
  year = {2025},
  doi = {10.1002/ardp.70004}
}
Kostenlos starten →